PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc, the main cloud platform for patient-centered drug growth, skilled document progress in 2020 because the COVID-19 pandemic drove demand for distant medical trial applied sciences. By minimizing the necessity for in-person website visits, Medable clients have achieved unprecedented outcomes – together with 3X quicker enrollment and over 90 p.c retention charges.
Medable onboarded greater than 50 new shoppers in 2020, as pharmaceutical, biotech, and medical analysis organizations used Medable’s software program to allow sufferers to take part in trials remotely — decreasing their dependence on bodily websites because of quarantines and social distancing. Decentralized trial adoption grew Medable revenues by greater than 400 p.c in 2020. Moreover, Medable launched 5 new merchandise to assist patient-centered analysis, and secured $118 million in total funding to speed up digital and decentralized medical trial adoption.
“COVID-19 accelerated patient-centered analysis by 5 years,” mentioned Dr. Michelle Longmire, CEO and co-founder of Medable. “2021 will likely be marked by the democratization of entry to analysis. Leveraging Medable, companions can present distant entry to new investigational medicines to sufferers worldwide. We’re driving radical transformation in medical trials by patient-centered applied sciences that take away conventional bottlenecks and rework key processes. In 2021, Medable will proceed to drive the emergence of a world ecosystem that really allows analysis anytime, anyplace and for each particular person.”
Digital and cell applied sciences performed a pivotal position for medical trials in 2020, enabling the continuation of in-flight analysis efforts through distant care whereas additionally accelerating growth of vaccines and therapeutics for COVID-19. Constructing on that have, Medable executives will share classes realized from 2020 and predictions for 2021, through 5 periods at this week’s Fierce JPM Week 2021 and Digital Medicine & MedTech Showcase occasions:
Rerouting: How Real-Time Patient Data Will Drive the Future of Healthcare
Moderator: Dr. Michelle Longmire, CEO, Medable
Panelists: Andy Coravos, CEO, Elektra Labs | Maria Fotiu, Govt VP of Decentralized Options, Syneos Well being | Thomas Switzer, Digital Well being Scientist, Genentech | Dr. Priyanka Agarwal, Director and Head of Digital Well being, Myokardia
Patient-Driven Therapeutics: Charting the Future of Healthcare
Introduced by: Dr. Michelle Longmire, CEO, Medable
Interviewed by: Sari Kaganoff, Normal Supervisor, Rock Well being
The Digitalization of Clinical Trials
Moderator: Maria Fotiu, Govt VP of Decentralized Options, Syneos Well being
Panelists: Dr. Michelle Longmire, CEO, Medable | Cathy Gao, VP, Sapphire Ventures | Juliet Moritz, COO, Illingworth Analysis
Hindsight is 2020: Lessons Learned from DCTs and 2021 Predictions
Introduced by: Allison Holland, Head, Decentralized Medical Trials, Medable | Craig Lipset, Business Founder and Advisor
User Experience: From the Patient, Site and Sponsor View
Introduced by: Rasmus Hogreffe, VP of DCT Innovation, Medable
Interviewed by: Karina Marocco, EBD Group
Please click on here for extra details about Medable’s presence at JPM 2021, or to schedule a gathering with Medable’s executives. For ongoing perception about decentralized trial adoption, recommendation and greatest practices, and patient-centered analysis, comply with Medable through our blog, LinkedIn, Twitter and Facebook channels.
Medable is on a mission to get efficient therapies to sufferers quicker by remodeling medical drug growth with disruptive applied sciences. The corporate’s digital platform streamlines design, recruitment, retention and information high quality for decentralized trials, changing siloed methods with built-in digital instruments, information and interfaces to speed up trial execution. Medable connects sufferers, websites and medical trial groups to enhance affected person entry, expertise, and outcomes. Medable is a privately held, venture-backed firm headquartered in Palo Alto, California.